KAIROS PHARMA LTD

Q2 2026 13F Holders

Symbol
KAPA
CUSIP
48301N104
Type
Equity
Class
COM
Num filings
14
Total reported value, excl. options
$371 k
Manager Report Date Value ($000) Shares Option Type